BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20508921)

  • 1. Genotypes and haplotypes of the estrogen receptor genes, but not the retinoblastoma-interacting zinc finger protein 1 gene, are associated with osteoporosis.
    Harsløf T; Husted LB; Carstens M; Stenkjaer L; Langdahl BL
    Calcif Tissue Int; 2010 Jul; 87(1):25-35. PubMed ID: 20508921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes.
    Ioannidis JP; Ralston SH; Bennett ST; Brandi ML; Grinberg D; Karassa FB; Langdahl B; van Meurs JB; Mosekilde L; Scollen S; Albagha OM; Bustamante M; Carey AH; Dunning AM; Enjuanes A; van Leeuwen JP; Mavilia C; Masi L; McGuigan FE; Nogues X; Pols HA; Reid DM; Schuit SC; Sherlock RE; Uitterlinden AG;
    JAMA; 2004 Nov; 292(17):2105-14. PubMed ID: 15523071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk.
    van Meurs JB; Schuit SC; Weel AE; van der Klift M; Bergink AP; Arp PP; Colin EM; Fang Y; Hofman A; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    Hum Mol Genet; 2003 Jul; 12(14):1745-54. PubMed ID: 12837697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-1213C polymorphism of estrogen receptor beta is associated with low bone mineral density and osteoporotic fractures.
    Kung AWC; Lai BMH; Ng MYM; Chan V; Sham PC
    Bone; 2006 Nov; 39(5):1097-1106. PubMed ID: 16777502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estrogen receptor 1 gene affects bone mineral density and osteoporosis treatment efficiency in Slovak postmenopausal women.
    Mondockova V; Adamkovicova M; Lukacova M; Grosskopf B; Babosova R; Galbavy D; Martiniakova M; Omelka R
    BMC Med Genet; 2018 Sep; 19(1):174. PubMed ID: 30241506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor beta polymorphisms are associated with bone mass in women and men: the Framingham Study.
    Shearman AM; Karasik D; Gruenthal KM; Demissie S; Cupples LA; Housman DE; Kiel DP
    J Bone Miner Res; 2004 May; 19(5):773-81. PubMed ID: 15068501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RIZ Pro704 insertion-deletion polymorphism, bone mineral density and fracture risk: the Rotterdam study.
    Stolk L; van Meurs JB; Arp PP; Hofman A; Pols HA; Uitterlinden AG
    Bone; 2008 Feb; 42(2):286-93. PubMed ID: 18037365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not.
    Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
    J Bone Miner Res; 2000 Nov; 15(11):2222-30. PubMed ID: 11092403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional polymorphisms in the P2X7 receptor gene are associated with osteoporosis.
    Husted LB; Harsløf T; Stenkjær L; Carstens M; Jørgensen NR; Langdahl BL
    Osteoporos Int; 2013 Mar; 24(3):949-59. PubMed ID: 22707062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotypes of promoter and intron 1 polymorphisms in the COLIA1 gene are associated with increased risk of osteoporosis.
    Husted LB; Harsløf T; Gonzalez-Bofill N; Schmitz A; Carstens M; Stenkjaer L; Langdahl BL
    Calcif Tissue Int; 2009 Feb; 84(2):85-96. PubMed ID: 19082910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of genetic variants of IL-6, IL6R, LRP5, ESR1 and SP7 genes on bone mineral density in postmenopausal Mexican-Mestizo women with obesity.
    Méndez JP; Rojano-Mejía D; Coral-Vázquez RM; Coronel A; Pedraza J; Casas MJ; Soriano R; García-García E; Vilchis F; Canto P
    Gene; 2013 Oct; 528(2):216-20. PubMed ID: 23891823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom.
    Albagha OM; McGuigan FE; Reid DM; Ralston SH
    J Bone Miner Res; 2001 Jan; 16(1):128-34. PubMed ID: 11149476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Height in pre- and postmenopausal women is influenced by estrogen receptor alpha gene polymorphisms.
    Schuit SC; van Meurs JB; Bergink AP; van der Klift M; Fang Y; Leusink G; Hofman A; van Leeuwen JP; Uitterlinden AG; Pols HA
    J Clin Endocrinol Metab; 2004 Jan; 89(1):303-9. PubMed ID: 14715865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD.
    Villadsen MM; Bünger MH; Carstens M; Stenkjaer L; Langdahl BL
    Osteoporos Int; 2005 Apr; 16(4):411-6. PubMed ID: 15300362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone.
    Albagha OM; Pettersson U; Stewart A; McGuigan FE; MacDonald HM; Reid DM; Ralston SH
    J Med Genet; 2005 Mar; 42(3):240-6. PubMed ID: 15744038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis.
    Ioannidis JP; Stavrou I; Trikalinos TA; Zois C; Brandi ML; Gennari L; Albagha O; Ralston SH; Tsatsoulis A;
    J Bone Miner Res; 2002 Nov; 17(11):2048-60. PubMed ID: 12412813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen.
    Kobayashi N; Fujino T; Shirogane T; Furuta I; Kobamatsu Y; Yaegashi M; Sakuragi N; Fujimoto S
    Maturitas; 2002 Mar; 41(3):193-201. PubMed ID: 11886765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.
    van Meurs JB; Trikalinos TA; Ralston SH; Balcells S; Brandi ML; Brixen K; Kiel DP; Langdahl BL; Lips P; Ljunggren O; Lorenc R; Obermayer-Pietsch B; Ohlsson C; Pettersson U; Reid DM; Rousseau F; Scollen S; Van Hul W; Agueda L; Akesson K; Benevolenskaya LI; Ferrari SL; Hallmans G; Hofman A; Husted LB; Kruk M; Kaptoge S; Karasik D; Karlsson MK; Lorentzon M; Masi L; McGuigan FE; Mellström D; Mosekilde L; Nogues X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Weber K; Ioannidis JP; Uitterlinden AG;
    JAMA; 2008 Mar; 299(11):1277-90. PubMed ID: 18349089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of COLIA1 polymorphisms and haplotypes on perimenopausal bone mass, postmenopausal bone loss and fracture risk.
    González-Bofill N; Husted LB; Harsløf T; Tofteng CL; Abrahamsen B; Eiken P; Vestergaard P; Langdahl BL
    Osteoporos Int; 2011 Apr; 22(4):1145-56. PubMed ID: 20571774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.